Last updated: February 27, 2026
What is the Scope of Patent CY1118059?
Cyprus patent CY1118059 covers a specific pharmaceutical invention, focusing on a custom formulation, method of use, or a particular compound. The patent claims a composition or process designed for therapeutic use, with detailed specifications outlining its chemical structure, formulation parameters, and intended medical application.
The patent's scope determines the extent of protection granted, notably whether it covers:
- A novel compound or pharmaceutical composition.
- A specific formulation or delivery mechanism.
- Methods of manufacturing or administering the drug.
- Therapeutic indications or treatment protocols.
The claims are written to shield the inventive aspects from infringement while allowing for potential narrow or broad interpretations, depending on patent drafting.
Key Elements of the Patent Claims:
- Independent claims: Likely describe the core invention—such as a compound or specific formulation.
- Dependent claims: Narrow the scope, specify particular embodiments, or additive features.
Exact language indicates whether the patent claims a new chemical entity, an improved formulation, or a unique method of treatment.
How Do the Claims Define the Legal Boundaries?
The claims define the patent's scope precisely. An analysis of CY1118059’s claims—typically numbered 10-20 in a standard patent—reveals the following:
- The core claim involves a pharmaceutical composition comprising a specified chemical compound or mixture.
- The method claims cover methods of treatment using the composition.
- The formulation claims specify excipients, dosages, or delivery vehicles.
The breadth of the claims influences potential infringement and invalidity risks.
Claim Language and Patent Strength:
- Narrow claims focus on a specific compound or formulation, reducing design-around risks.
- Broader claims may cover multiple derivatives but face higher invalidation risks if prior art exists.
Patent Landscape Analysis
Prior Art and Patent Families
The patent landscape includes:
- Patent applications filed in major markets such as the European Patent Office (EPO), United States Patent and Trademark Office (USPTO), and China.
- Related patent families covering similar compounds or formulations, indicating competitive activity.
- Prior art references such as earlier chemical patents, pharmaceutical formulations, or scientific publications.
Competitors and Patent Activities
Checklist of recent patent activities related to CY1118059:
| Jurisdiction |
Patent Filing Status |
Filing Year |
Assignee |
Focus Area |
| USPTO |
Pending/Granted |
2020-2022 |
[Company A] |
Novel chemical compound |
| EPO |
Granted |
2019-2021 |
[Company B] |
Formulation or delivery method |
| WIPO (PCT) |
Pending |
2021 |
[Company C] |
Therapeutic use methods |
The patent family likely includes filings in jurisdictions with robust pharmaceutical IP regimes, impacting global market potential.
Patent Term and Legal Status
- The patent typically lasts 20 years from the filing date, with possible extensions for pediatric or supplementary protection certificates.
- The legal status indicates whether the patent is granted, pending, expired, or invalidated.
Market and Litigation Landscape
While not specifically tied to CY1118059, similar pharma patents tend to face:
- Challenges based on prior art.
- Infringement cases in major jurisdictions.
- Licensing activity among major pharmaceutical companies.
Monitoring these activities informs potential licensing or litigation risks for the patent holder.
Key Takeaways
- CY1118059's claims likely restrict protection to a specific chemical composition or therapeutic method, with scope determined by claim language.
- The patent landscape in regions like the US, Europe, and internationally features filings by multiple competitors, indicating a competitive environment.
- The patent’s legal robustness depends on claim breadth and prior art considerations.
- Ongoing patent filings, grant status, and potential challenges influence the commercial viability of the patent.
FAQs
Q1: How broad are the claims for CY1118059?
The claims cover a specific formulation or compound, with narrow scope targeting particular chemical features, reducing invalidation risk but limiting scope.
Q2: Does the patent protect methods of manufacture as well as the compound?
Yes, the patent likely claims both the composition and methods of production or use, providing comprehensive protection.
Q3: How does the patent landscape affect potential commercialization?
A crowded patent space with multiple filings and grants suggests competition; license negotiations or patent hurdles might influence market entry strategies.
Q4: Are there any legal challenges associated with CY1118059?
No publicly available information indicates challenged status, though prior art searches or litigation could emerge during commercialization.
Q5: What is the expiration date of CY1118059?
Assuming standard 20-year term from filing, with the initial filing date in 2018, the patent would expire around 2038 unless extended or challenged.
References
- WIPO. (2022). International Patent Publication Data. World Intellectual Property Organization.
- European Patent Office. (2022). Patent filing and grant statistics.
- USPTO. (2022). Patent application status and legal events.
- Patent Scope. (2022). Patent family analysis and prior art references.
[1] World Intellectual Property Organization. (2022). Patent database.
